{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"19.36","value":"84.66"},{"groupId":"OG001","spread":"18.97","value":"84.76"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"190"},{"groupId":"OG001","value":"196"}],"units":"Participants"}],"title":"Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"17.96","value":"-1.94"},{"groupId":"OG001","spread":"13.88","value":"1.81"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"159"},{"groupId":"OG001","value":"165"}],"units":"Participants"}],"title":"CFB at Cycle 3 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.38","value":"-10.40"},{"groupId":"OG001","spread":"19.51","value":"26.44"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"CFB at Cycle 4 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"15.38","value":"-1.38"},{"groupId":"OG001","spread":"14.15","value":"2.37"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"144"},{"groupId":"OG001","value":"154"}],"units":"Participants"}],"title":"CFB at Cycle 5 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"17.23","value":"-0.52"},{"groupId":"OG001","spread":"16.45","value":"0.40"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"151"},{"groupId":"OG001","value":"149"}],"units":"Participants"}],"title":"CFB at End of Induction Treatment"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"15.36","value":"3.75"},{"groupId":"OG001","spread":"14.85","value":"4.60"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"108"},{"groupId":"OG001","value":"139"}],"units":"Participants"}],"title":"CFB at Follow-up Month 2"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"13.39","value":"3.81"},{"groupId":"OG001","spread":"17.06","value":"5.18"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"96"},{"groupId":"OG001","value":"127"}],"units":"Participants"}],"title":"CFB at Follow-up Month 4"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"12.19","value":"3.26"},{"groupId":"OG001","spread":"13.72","value":"6.07"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"79"},{"groupId":"OG001","value":"117"}],"units":"Participants"}],"title":"CFB at Follow-up Month 6"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"12.39","value":"1.36"},{"groupId":"OG001","spread":"14.21","value":"5.36"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"76"},{"groupId":"OG001","value":"109"}],"units":"Participants"}],"title":"CFB at Follow-up Month 8"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"13.16","value":"3.52"},{"groupId":"OG001","spread":"15.96","value":"4.94"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"59"},{"groupId":"OG001","value":"96"}],"units":"Participants"}],"title":"CFB at Follow-up Month 10"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"15.14","value":"2.05"},{"groupId":"OG001","spread":"15.72","value":"6.13"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"95"}],"units":"Participants"}],"title":"CFB at Follow-up Month 12"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"11.92","value":"2.25"},{"groupId":"OG001","spread":"14.30","value":"5.13"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"47"},{"groupId":"OG001","value":"91"}],"units":"Participants"}],"title":"CFB at Follow-up Month 14"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"14.15","value":"0.75"},{"groupId":"OG001","spread":"15.11","value":"6.78"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"43"},{"groupId":"OG001","value":"87"}],"units":"Participants"}],"title":"CFB at Follow-up Month 16"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"11.30","value":"1.36"},{"groupId":"OG001","spread":"14.62","value":"7.26"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"79"}],"units":"Participants"}],"title":"CFB at Follow-up Month 18"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"15.21","value":"-0.64"},{"groupId":"OG001","spread":"14.99","value":"6.36"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"35"},{"groupId":"OG001","value":"77"}],"units":"Participants"}],"title":"CFB at Follow-up Month 20"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"14.54","value":"2.26"},{"groupId":"OG001","spread":"17.88","value":"5.30"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"75"}],"units":"Participants"}],"title":"CFB at Follow-up Month 22"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"13.44","value":"-0.14"},{"groupId":"OG001","spread":"17.88","value":"5.30"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"72"}],"units":"Participants"}],"title":"CFB at Follow-up Month 24"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"14.80","value":"0.84"},{"groupId":"OG001","spread":"16.22","value":"3.84"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"86"},{"groupId":"OG001","value":"114"}],"units":"Participants"}],"title":"CFB at Final Follow-up"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.77","value":"2.30"},{"groupId":"OG001","spread":"18.44","value":"5.53"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"63"}],"units":"Participants"}],"title":"CFB at Extension Follow Up Month 6"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"14.01","value":"4.02"},{"groupId":"OG001","spread":"15.69","value":"7.31"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"50"}],"units":"Participants"}],"title":"CFB at Extension Follow Up Month 18"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"13.35","value":"10.04"},{"groupId":"OG001","spread":"17.59","value":"7.07"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"42"}],"units":"Participants"}],"title":"CFB at Extension Follow Up Month 24"}],"denoms":[{"counts":[{"groupId":"OG000","value":"190"},{"groupId":"OG001","value":"196"}],"units":"Participants"}],"description":"TOI is the sum of 3 sub-scales (physical well-being, functional well-being, and Lymphoma sub-scale) of FACT-Lym which includes total 29 items; responses to each item range from 0, \"Not at all\" to 4, \"Very much\". Total score ranges from 0-116. Higher scores indicate a better PRO/QoL. In timeframe, follow-up months represents months after end of induction (e.g. Follow-up Month 2 is 2 months after end of induction) and extension follow-up months represents months after end of 2 years normal follow-up (e.g. extension follow-up Month 6 is 6 months after end of normal 2 year follow-up).","dispersionType":"Standard Deviation","groups":[{"description":"Participants received Bendamustine 120 mg/m\\^2 IV infusion on Days 1 and 2 of each 28-day cycle for up to six cycles.","id":"OG000","title":"Bendamustine Alone"},{"description":"Induction phase: Participants received Bendamustine 90 mg/m\\^2 IV on Days 2 and 3 of Cycle 1 and on Days 1 and 2 of Cycles 2-6 (28-day cycles) for the first 10 participants and on Days 1 and 2 of each 28-day cycle for Cycles 1-6 for remaining participants. Participants also received obinutuzumab 1000 mg IV infusion on Days 1, 8, and 15 of Cycle 1; Day 1 of Cycles 2-6. Maintenance phase: Participants with CR, PR or SD then received obinutuzumab 1000 mg IV infusion every 2 months until disease progression or for up to 2 years (whichever occurred first).","id":"OG001","title":"Obinutuzumab + Bendamustine"}],"paramType":"MEAN","populationDescription":"ITT population. Here, number of participants analyzed signified those participants who were evaluable for this outcome.","reportingStatus":"POSTED","timeFrame":"Baseline, Day 1 of Cycles 3, 4, 5, End of induction treatment (up to Month 6); Follow-up Months 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, Final Follow-up (up to 2 years after end of induction); Extension follow-up Months 6, 18 and 24","title":"CFB in FACT-Lym Trial Outcome Index (TOI)","type":"SECONDARY","unitOfMeasure":"Units on a scale"}